Last reviewed · How we verify
18-month regimen containing 6 anti-TB drugs — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
18-month regimen containing 6 anti-TB drugs (18-month regimen containing 6 anti-TB drugs) — Beijing Chest Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 18-month regimen containing 6 anti-TB drugs TARGET | 18-month regimen containing 6 anti-TB drugs | Beijing Chest Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 18-month regimen containing 6 anti-TB drugs CI watch — RSS
- 18-month regimen containing 6 anti-TB drugs CI watch — Atom
- 18-month regimen containing 6 anti-TB drugs CI watch — JSON
- 18-month regimen containing 6 anti-TB drugs alone — RSS
Cite this brief
Drug Landscape (2026). 18-month regimen containing 6 anti-TB drugs — Competitive Intelligence Brief. https://druglandscape.com/ci/18-month-regimen-containing-6-anti-tb-drugs. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab